NEOPLASMS BY SITE
Clinical trials for NEOPLASMS BY SITE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY SITE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug EO-3021 tested in advanced cancer patients
Disease control TerminatedThis early-stage study tested an experimental drug called EO-3021 in adults with advanced solid tumors, especially stomach cancer, that have a specific marker (CLDN18.2). The main goals were to check safety and find the right dose. The study was stopped early, so results are limi…
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE1 • Sponsor: Elevation Oncology • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
New drug cocktail for advanced kidney cancer shows early promise, but trial halted
Disease control TerminatedThis study tested a new drug (NKT2152) combined with two other medicines (palbociclib and sasanlimab) in people with advanced clear cell kidney cancer that had worsened after prior treatments. The goal was to see if the combination was safe and could shrink tumors. The trial was …
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
Targeted lung cancer drug tested against chemo in phase 3 trial
Disease control TerminatedThis study tested a new targeted pill, pralsetinib, against standard chemotherapy for people with a specific type of advanced lung cancer (RET fusion-positive) who had not yet received treatment. The goal was to see if the targeted drug could delay cancer growth better than chemo…
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 18, 2026 11:59 UTC